Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4,

M W Elmlinger1, W Kühnel, H G Lambrecht

  • 1University Children's Hospital, Paediatric Endocrinology Section, Tuebingen, Germany. martin.elmlinger@med.uni-tuebingen.de

Insights

Establishing pediatric thyroid hormone reference intervals is crucial for development. This study provides new reference ranges for thyroid-stimulating hormone (TSH) and thyroid hormones from birth to adulthood using automated chemiluminescence immunoassay.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Chemistry
  • Immunoassay Technology

Background:

  • Thyroid dysfunction can significantly impact child development.
  • Establishing accurate reference intervals for thyroid hormones is essential for diagnosis and management in pediatric populations.
  • Existing reference ranges may not adequately cover the dynamic changes from birth through adolescence.

Purpose of the Study:

  • To establish comprehensive reference intervals for key thyroid hormones and thyrotropin (TSH) in euthyroid individuals from birth to adulthood.
  • To utilize the automated chemiluminescence immunoassay system (Immulite) for reliable and standardized measurements.
  • To provide age- and sex-specific reference data for clinical assessment.

Main Methods:

  • Serum samples from 762 euthyroid newborns, children, and adolescents (1 day to 19 years) were analyzed.
  • Measurements included triiodothyronine (T3), free T3 (fT3), thyroxine (T4), free T4 (fT4), thyroxine binding globulin (TBG), and TSH.
  • Non-normal distribution necessitated the calculation of 2.5th, 50th, and 97.5th percentiles for central 95% intervals.

Main Results:

  • Thyroid hormone and TSH concentrations showed significant variations, with higher medians in the neonatal period (up to 3.2-fold).
  • Thyroxine (T4) levels increased in the first month of life.
  • Thyroxine binding globulin (TBG) increased with age, peaking around 5 years, while other parameters generally decreased from 1 year onwards. No significant sex differences were observed.

Conclusions:

  • Reference intervals for thyroid hormones and TSH vary considerably after the neonatal period and across childhood and adolescence.
  • The established reference intervals are applicable for assessing thyroid status in pediatric patients using the Immulite/Immulite 2000 system.
  • Thyroid hormone levels do not correlate with sexual development, with the exception of a slight decrease in TBG during puberty.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...